Effect of Medication Reviews Performed in High Risk Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01819974|
Recruitment Status : Unknown
Verified November 2013 by University of Aarhus.
Recruitment status was: Recruiting
First Posted : March 28, 2013
Last Update Posted : November 28, 2013
|Condition or disease||Intervention/treatment||Phase|
|Patients in Highest Medication Error Risk||Other: Stratified medication review||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||600 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Medication Reviews in Hospitalized High-risk Patients - a Randomised Controlled Trial|
|Study Start Date :||April 2013|
|Estimated Primary Completion Date :||November 2013|
|Estimated Study Completion Date :||May 2014|
No Intervention: Control
The normal procedure at the ward
Active Comparator: Stratified medication review
Medication review performed by either a clinical pharmacist or a clinical pharmacologist in patients with highest medication error risk
Other: Stratified medication review
A mediciation review will be performed in patients with high medication error rik. Patients in the highest risk will receive the medication review from a clinical pharmacologist whereas patients assessed in lesser risk will receive the medication review from a clinical pharmacist.
- Medication errors [ Time Frame: During hospitalization ie. between 8 hours and approximately 20 days ]Medication errors are defined as errors in prescribing that has the potential to harm patients or actually harm patients. This will be assessed by checking the medical records. Two independent experts will do this.
- hospital readmissions (all-cause) [ Time Frame: 3 months after discharge ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01819974
|Contact: Dorthe K Bonnerup, Mscemail@example.com|
|Contact: Lars P Nielsen, MDfirstname.lastname@example.org|
|Aarhus University Hospital||Recruiting|
|Aarhus, Denmark, 8000|
|Principal Investigator: Dorthe K Bonnerup, Msc|